Burbank, California-based The Walt Disney Company (DIS) operates as an entertainment company worldwide. Valued at $204.5 ...

Diversified Energy's acquisitions will not only expand its asset base but also grow operational capacities and profitability.

That’s because it’s gradually dawning on investors that they no longer can count on lower interest rates and inflation to support higher stock and bond prices. They are realizing that ...

Looking to 2025, analysts predict Amazon stock will see a slight increase. According to current forecasts, AMZN is expected to hit $269.89 by June 2025, representing a 19.45% decrease from its ...

Stock market crash: Indian stocks came under significant selling pressure in Friday's trading session, January 17, driven by a sharp sell-off in banking and IT counters, which caused the frontline ...

At the end of 2025, we forecast Broadcom’s stock to be trading for $204.27 based on revenue of $60.492 billion, a net income of $34.224 billion, and an EPS of $6.19. The following year ...

Netflix Inc.’s stock was flat Friday after Benchmark analysts reiterated their sell rating on the stock even as they raised their price target by 30%, arguing that it’s looking overvalued in a ...

FICCI has revised India's GDP growth forecast to 6.4% for FY 2024-25, down from 7.0%. Consumer spending is expected to rise, driven by positive developments in agriculture and rural areas.

AMD stock (NASDAQ:AMD) has seen a meaningful sell-off over the past week, declining by about 11% over the last five trading days. The stock also remains down by about 25% since early 2024.

No new positions are allowed when the stock exchanges place F&O contracts in a particular stock in the ban period.(Photo: NSE) F&O ban list: The National Stock Exchange (NSE) banned trading in ...

Adjusted EPS of $1.07 exceeded the estimated $1.05 and last year’s $0.99. Revenue for Q4 was $7.01 billion, slightly ahead of the $7 billion estimate and up from $6,88 billion a year ago ...

Eli Lilly (LLY) stock is in focus after the pharmaceutical giant plunged 6.6% in the prior session to lead S&P 500 decliners as it lowered its 2024 full-year revenue forecast. The drugmaker said ...